Literature DB >> 15790756

Liver disease with altered bile acid transport in Niemann-Pick C mice on a high-fat, 1% cholesterol diet.

Robert P Erickson1, Achyut Bhattacharyya, Robert J Hunter, Randall A Heidenreich, Nathan J Cherrington.   

Abstract

Cholestatic hepatitis is frequently found in Niemann-Pick C (NPC) disease. We studied the influence of diet and the low density lipoprotein receptor (LDLR, Ldlr in mice, known to be the source of most of the stored cholesterol) on liver disease in the mouse model of NPC. Npc1-/- mice of both sexes, with or without the Ldlr knockout, were fed a 18% fat, 1% cholesterol ("high-fat") diet and were evaluated by chemical and histological methods. Bile acid transporters [multidrug resistance protein (Mrps) 1-5; Ntcp, Bsep, and OatP1, 2, and 4] were quantitated by real-time RT-PCR. Many mice died prematurely (within 6 wk) with hepatomegaly. Histopathology showed an increase in macrophage and hepatocyte lipids independent of Ldlr genotype. Non-zone-dependent diffuse fibrosis was found in the surviving mice. Serum alanine aminotransferase was elevated in Npc1-/- mice on the regular diet and frequently became markedly elevated with the high-fat diet. Serum cholesterol was increased in the controls but not the Npc1-/- mice on the high-fat diet; it was massively increased in the Ldlr-/- mice. Esterified cholesterol was greatly increased by the high-fat diet, independent of Ldlr genotype. gamma-Glutamyltransferase was also elevated in Npc1-/- mice, more so on the high-fat diet. Mrps 1-5 were elevated in Npc1-/- liver and became more elevated with the high-fat diet; Ntcp, Bsep, and OatP2 were elevated in Npc1-/- liver and were suppressed by the high-fat diet. In conclusion, Npc1-/- mice on a high-fat diet provide an animal model of NPC cholestatic hepatitis and indicate a role for altered bile acid transport in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790756     DOI: 10.1152/ajpgi.00568.2004

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  13 in total

Review 1.  Current controversies in Niemann-Pick C1 disease: steroids or gangliosides; neurons or neurons and glia.

Authors:  Robert P Erickson
Journal:  J Appl Genet       Date:  2013-01-05       Impact factor: 3.240

2.  Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann Pick type C1.

Authors:  M Paulina Ordonez; Elizabeth A Roberts; Chelsea U Kidwell; Shauna H Yuan; Warren C Plaisted; Lawrence S B Goldstein
Journal:  Hum Mol Genet       Date:  2012-03-21       Impact factor: 6.150

3.  Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1.

Authors:  Celine V M Cluzeau; Dawn E Watkins-Chow; Rao Fu; Bhavesh Borate; Nicole Yanjanin; Michelle K Dail; Cristin D Davidson; Steven U Walkley; Daniel S Ory; Christopher A Wassif; William J Pavan; Forbes D Porter
Journal:  Hum Mol Genet       Date:  2012-05-22       Impact factor: 6.150

4.  Reduced VLDL clearance in Apoe(-/-)Npc1(-/-) mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels.

Authors:  Minako Ishibashi; David Masson; Marit Westerterp; Nan Wang; Scott Sayers; Rong Li; Carrie L Welch; Alan R Tall
Journal:  J Lipid Res       Date:  2010-06-18       Impact factor: 5.922

5.  Niemann-Pick C1-deficient mice lacking sterol O-acyltransferase 2 have less hepatic cholesterol entrapment and improved liver function.

Authors:  Adam M Lopez; Ryan D Jones; Joyce J Repa; Stephen D Turley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-07       Impact factor: 4.052

6.  Genetic variation in the mouse model of Niemann Pick C1 affects female, as well as male, adiposity, and hepatic bile transporters but has indeterminate effects on caveolae.

Authors:  David A Jelinek; Bita Maghsoodi; Ivan A Borbon; Rhiannon N Hardwick; Nathan J Cherrington; Robert P Erickson
Journal:  Gene       Date:  2011-10-14       Impact factor: 3.688

7.  Evaluation of an anti-tumor necrosis factor therapeutic in a mouse model of Niemann-Pick C liver disease.

Authors:  Melanie Vincent; Naomi L Sayre; Mark J Graham; Rosanne M Crooke; David J Shealy; Laura Liscum
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

8.  In vivo antisense oligonucleotide reduction of NPC1 expression as a novel mouse model for Niemann Pick type C- associated liver disease.

Authors:  Victoria M Rimkunas; Mark J Graham; Rosanne M Crooke; Laura Liscum
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

9.  Variation in NPC1, the gene encoding Niemann-Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and/or aging in the Polish population.

Authors:  Robert P Erickson; Katherine Larson-Thomé; Lyndon Weberg; Aleksandra Szybinska; Malgorzata Mossakowska; Maria Styczynska; Maria Barcikowska; Jacek Kuznicki
Journal:  Neurosci Lett       Date:  2008-09-24       Impact factor: 3.046

10.  The role of decreased levels of Niemann-Pick C1 intracellular cholesterol transport on obesity is reversed in the C57BL/6J, metabolic syndrome mouse strain: a metabolic or an inflammatory effect?

Authors:  Ivan Borbon; Erin Campbell; Wangjing Ke; Robert P Erickson
Journal:  J Appl Genet       Date:  2012-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.